Clinical Trials Logo

Merkel Cell Carcinoma, Stage III clinical trials

View clinical trials related to Merkel Cell Carcinoma, Stage III.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04291885 Recruiting - Clinical trials for Neuroendocrine Tumors

Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

I-MAT
Start date: October 26, 2020
Phase: Phase 2
Study type: Interventional

The I-MAT trial is a randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma aiming to explore the efficacy of avelumab as adjuvant immunotherapy.